Today's most important upgrades

Pinterest (NYSE: PINS) shares surged more than 12% intra-day today after Piper Sandler upgraded the company to Overweight from Neutral and raised its price target to $30 from $25. The analysts see multiple tailwinds into 2023, independent of the health of the ad market.

Goldman Sachs upgraded Pfizer (NYSE: PFE) to Buy from Neutral and raised its price target to $60.00 from $47.00. Shares rose more than 3% intra-day today following the company’s Investor Day, where it said it expects annual revenue from its mRNA vaccine portfolio to reach $10-15 billion by 2030.

Cowen upgraded Equinix (NASDAQ: EQIX) to Outperform from Market Perform with a price target of $811 and named it a Best 2023 stock idea. The analysts see price increases as an underappreciated growth tailwind and do not expect higher power prices to weigh on 2023 EBITDA and AFFO/share. The company’s shares gained more than 3% intra-day today.

Goldman Sachs upgraded Humana (NYSE: HUM) to Buy from Neutral with a price target of $652.00. The analysts see a strengthening earnings outlook as improved competitive positioning in MA has reaccelerated member growth for 2023 and could deliver multiple years of share gains as many peers face Stars headwinds in 2024.

By Davit Kirakosyan

Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here

You May Also Be Interested In

• UBS lists 13 high-conviction TMT stock ideas
• TD Cowen on Oracle (ORCL): 'Solid 4Q & Guide'
• SpaceX: New Street Research sees 22% upside from proposed IPO price